Tyler Retina Consultants | ClinicalTrials HQ

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase 3 Study of Intravitreal 4D-150 in Adults With Diabetic Macular Edema (DME) (4D-150-C005)	eye disorder	Recruiting	Phase 3	2026-10-09		NCT07867080
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME	diabetic macular edema	Active, not recruiting	Phase 3	2026-10-02		NCT07449936
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME	diabetic macular edema	Active, not recruiting	Phase 3	2026-10-02		NCT07449923
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56	wet macular degeneration	Active, not recruiting	Phase 3	2026-09-03		NCT06683742
A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUGANO) Primary Efficacy Will be Determined at Week 56	wet macular degeneration	Active, not recruiting	Phase 3	2026-09-03		NCT06668064
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio	Geographic Atrophy Secondary to Age-related Macular Degeneration	Recruiting	Phase 2	2026-06-24		NCT07215390
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration	eye disorder, macular degeneration, retinal degeneration, retinal disorder, wet macular degeneration	Recruiting	Phase 3	2026-04-16		NCT07064759